Tyche Wealth Partners LLC acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 5,902 shares of the financial services provider’s stock, valued at approximately $802,000.
A number of other large investors have also recently bought and sold shares of the business. Glass Jacobson Investment Advisors llc grew its position in shares of iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 122 shares during the last quarter. PCA Investment Advisory Services Inc. bought a new position in iShares Biotechnology ETF in the 2nd quarter worth about $28,000. Values First Advisors Inc. acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $43,000. Horizon Bancorp Inc. IN bought a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $44,000. Finally, Tennessee Valley Asset Management Partners acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $44,000. Institutional investors own 62.45% of the company’s stock.
iShares Biotechnology ETF Trading Up 0.1 %
Shares of NASDAQ:IBB traded up $0.16 during trading on Wednesday, reaching $127.13. The company had a trading volume of 240,175 shares, compared to its average volume of 1,786,673. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16. The firm’s fifty day moving average is $135.63 and its 200 day moving average is $129.57.
iShares Biotechnology ETF Dividend Announcement
About iShares Biotechnology ETF
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
See Also
- Five stocks we like better than iShares Biotechnology ETF
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- ASML Fires Warning Shot For Tech Investors
- Consumer Staples Stocks, Explained
- Prologis Stock Leading U.S. Logistics Boom
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.